-
2
-
-
33644607018
-
Multiple sclerosis - the plaque and its pathogenesis
-
Frohman EM, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006;354: 942-955.
-
(2006)
N Engl J Med
, vol.354
, pp. 942-955
-
-
Frohman, E.M.1
Racke, M.K.2
Raine, C.S.3
-
3
-
-
33947095512
-
The pathology of MS: New insights and potential clinical applications
-
Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. Neurologist 2007; 13:45-56.
-
(2007)
Neurologist
, vol.13
, pp. 45-56
-
-
Pittock, S.J.1
Lucchinetti, C.F.2
-
4
-
-
33845294412
-
Remyelination is extensive in a subset of multiple sclerosis patients
-
Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006;129:3165-3172.
-
(2006)
Brain
, vol.129
, pp. 3165-3172
-
-
Patrikios, P.1
Stadelmann, C.2
Kutzelnigg, A.3
-
5
-
-
2542619146
-
Molecular changes in neurons in MS: Altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na/Ca exchanger
-
Craner MJ, Newcombe J, Black JA, et al. Molecular changes in neurons in MS: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na/Ca exchanger. Proc Natl Acad Sci U S A 2004;101:8168-8173.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 8168-8173
-
-
Craner, M.J.1
Newcombe, J.2
Black, J.A.3
-
6
-
-
33751208544
-
Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis
-
Coman I, Aigrot MS, Seilhean D, et al. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain 2006;129: 3186-3195.
-
(2006)
Brain
, vol.129
, pp. 3186-3195
-
-
Coman, I.1
Aigrot, M.S.2
Seilhean, D.3
-
7
-
-
0032576752
-
Axonal transection in the lesions of multiple sclerosis
-
Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338: 278-285.
-
(1998)
N Engl J Med
, vol.338
, pp. 278-285
-
-
Trapp, B.D.1
Peterson, J.2
Ransohoff, R.M.3
-
8
-
-
0037441487
-
Axonal loss in the pathology of MS: Consequences for understanding the progressive phase of the disease
-
Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003;206:165-171.
-
(2003)
J Neurol Sci
, vol.206
, pp. 165-171
-
-
Bjartmar, C.1
Wujek, J.R.2
Trapp, B.D.3
-
9
-
-
0036136532
-
Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis
-
Wujek JR, Bjartmar C, Richer E, et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 2002; 61:23-32.
-
(2002)
J Neuropathol Exp Neurol
, vol.61
, pp. 23-32
-
-
Wujek, J.R.1
Bjartmar, C.2
Richer, E.3
-
10
-
-
0031852514
-
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
-
De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121:1469-1477.
-
(1998)
Brain
, vol.121
, pp. 1469-1477
-
-
De Stefano, N.1
Matthews, P.M.2
Fu, L.3
-
11
-
-
1642482932
-
Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation
-
Inglese M, Mancardi GL, Pagani E, et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry 2004;75: 643-644.
-
(2004)
J Neurol Neurosurg Psychiatry
, vol.75
, pp. 643-644
-
-
Inglese, M.1
Mancardi, G.L.2
Pagani, E.3
-
12
-
-
31544467633
-
The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy
-
Coles AJ, Cox A, Le Page E, et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 2006;253:98-108.
-
(2006)
J Neurol
, vol.253
, pp. 98-108
-
-
Coles, A.J.1
Cox, A.2
Le Page, E.3
-
13
-
-
34249749383
-
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
-
Metz I, Lucchinetti CF, Openshaw H, et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 2007; 130:1254-1262.
-
(2007)
Brain
, vol.130
, pp. 1254-1262
-
-
Metz, I.1
Lucchinetti, C.F.2
Openshaw, H.3
-
14
-
-
0036546066
-
New concepts in the immunopathogenesis of multiple sclerosis
-
Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301.
-
(2002)
Nat Rev Neurosci
, vol.3
, pp. 291-301
-
-
Hemmer, B.1
Archelos, J.J.2
Hartung, H.P.3
-
15
-
-
0029087953
-
Voltage-gated calcium channels in CNS white matter: Role in anoxic injury
-
Fern R, Ransom BR, Waxman SG. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J Neurophysiol 1995;74:369-377.
-
(1995)
J Neurophysiol
, vol.74
, pp. 369-377
-
-
Fern, R.1
Ransom, B.R.2
Waxman, S.G.3
-
16
-
-
0033616414
-
The role of voltage-gated Ca2+ channels in anoxic injury of spinal cord white matter
-
Imaizumi T, Kocsis JD, Waxman SG. The role of voltage-gated Ca2+ channels in anoxic injury of spinal cord white matter. Brain Res 1999;817:84-92.
-
(1999)
Brain Res
, vol.817
, pp. 84-92
-
-
Imaizumi, T.1
Kocsis, J.D.2
Waxman, S.G.3
-
17
-
-
33644520285
-
NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia
-
Micu I, Coderre E, Jiang Q, et al. NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature 2006;439:988-992.
-
(2006)
Nature
, vol.439
, pp. 988-992
-
-
Micu, I.1
Coderre, E.2
Jiang, Q.3
-
18
-
-
0141750468
-
Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors
-
Ouardouz M, Nikolaeva M, Coderre E, et al. Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 2003;40:53-63.
-
(2003)
Neuron
, vol.40
, pp. 53-63
-
-
Ouardouz, M.1
Nikolaeva, M.2
Coderre, E.3
-
19
-
-
0026556810
-
Ionic mechanisms of anoxic injury in mammalian CNS white matter: Role of Na+ channels and Na+-Ca2+ exchanger
-
Stys PK, Waxman SG, Ransom BR. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na+-Ca2+ exchanger. J Neurosci 1992;12: 430-439.
-
(1992)
J Neurosci
, vol.12
, pp. 430-439
-
-
Stys, P.K.1
Waxman, S.G.2
Ransom, B.R.3
-
20
-
-
0035875713
-
AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter
-
Tekkok SB, Goldberg MP. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001;21: 4237-4248.
-
(2001)
J Neurosci
, vol.21
, pp. 4237-4248
-
-
Tekkok, S.B.1
Goldberg, M.P.2
-
21
-
-
20444386558
-
General mechanisms of axonal damage and its prevention
-
Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci 2005;233:3-13.
-
(2005)
J Neurol Sci
, vol.233
, pp. 3-13
-
-
Stys, P.K.1
-
22
-
-
33644817756
-
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
-
Dutti R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006;59:478-489.
-
(2006)
Ann Neurol
, vol.59
, pp. 478-489
-
-
Dutti, R.1
McDonough, J.2
Yin, X.3
-
23
-
-
33846025116
-
Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis
-
Qi X, Lewin AS, Sun L, et al. Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 2006;281:31950-31962.
-
(2006)
J Biol Chem
, vol.281
, pp. 31950-31962
-
-
Qi, X.1
Lewin, A.S.2
Sun, L.3
-
24
-
-
2142814324
-
Axonal degeneration in MS: Is it time for neuroprotective strategies?
-
Stys PK. Axonal degeneration in MS: is it time for neuroprotective strategies? Ann Neurol 2004;55:601-603.
-
(2004)
Ann Neurol
, vol.55
, pp. 601-603
-
-
Stys, P.K.1
-
25
-
-
0242508548
-
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo
-
Lo AC, Saab CY, Black JA, et al. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 2003;90:3566-3571.
-
(2003)
J Neurophysiol
, vol.90
, pp. 3566-3571
-
-
AC, L.1
Saab, C.Y.2
Black, J.A.3
-
26
-
-
2142760098
-
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
-
Bechtold DA, Kapoor R, Smith KJ. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 2004;55:607-616.
-
(2004)
Ann Neurol
, vol.55
, pp. 607-616
-
-
Bechtold, D.A.1
Kapoor, R.2
Smith, K.J.3
-
27
-
-
33744489487
-
Axonal protection achieved in a model of multiple sclerosis using lamotrigine
-
Bechtold DA, Miller SJ, Dawson AC, et al. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol 2006;253:1542-1551.
-
(2006)
J Neurol
, vol.253
, pp. 1542-1551
-
-
Bechtold, D.A.1
Miller, S.J.2
Dawson, A.C.3
-
28
-
-
33751166454
-
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
-
Black JA, Liu S, Hains BC, et al. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 2006;129:3196-3208.
-
(2006)
Brain
, vol.129
, pp. 3196-3208
-
-
Black, J.A.1
Liu, S.2
Hains, B.C.3
-
29
-
-
0033958462
-
Glutamate excitotoxicity in a model of multiple sclerosis
-
Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000;6:67-70.
-
(2000)
Nat Med
, vol.6
, pp. 67-70
-
-
Pitt, D.1
Werner, P.2
Raine, C.S.3
-
30
-
-
0033963231
-
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
-
Smith T, Groom A, Zhu B, et al. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000;6: 62-66.
-
(2000)
Nat Med
, vol.6
, pp. 62-66
-
-
Smith, T.1
Groom, A.2
Zhu, B.3
-
32
-
-
0141861944
-
Riluzole suppresses experimental autoimmune encephalomyelitis: Implications for the treatment of multiple sclerosis
-
Gilgun-Sherki Y, Panet H, Melamed E, et al. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Brain Res 2003; 989:196-204.
-
(2003)
Brain Res
, vol.989
, pp. 196-204
-
-
Gilgun-Sherki, Y.1
Panet, H.2
Melamed, E.3
-
33
-
-
3543068828
-
Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis
-
Brand-Schieber E, Werner P. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis. Exp Neurol 2004;189:5-9.
-
(2004)
Exp Neurol
, vol.189
, pp. 5-9
-
-
Brand-Schieber, E.1
Werner, P.2
-
34
-
-
34547773583
-
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine
-
Black JA, Liu S, Carrithers M, et al. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine. Ann Neurol 2007;62:21-33.
-
(2007)
Ann Neurol
, vol.62
, pp. 21-33
-
-
Black, J.A.1
Liu, S.2
Carrithers, M.3
|